178 related articles for article (PubMed ID: 37848981)
1. Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR.
Liu C; Lu C; Yixi L; Hong J; Dong F; Ruan S; Hu T; Zhao X
Breast Cancer Res; 2023 Oct; 25(1):124. PubMed ID: 37848981
[TBL] [Abstract][Full Text] [Related]
2. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
[TBL] [Abstract][Full Text] [Related]
4. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
Han M; Gu Y; Lu P; Li J; Cao H; Li X; Qian X; Yu C; Yang Y; Yang X; Han N; Dou D; Hu J; Dong H
Mol Cancer; 2020 Feb; 19(1):26. PubMed ID: 32020881
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract][Full Text] [Related]
6. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
Han M; Hu J; Lu P; Cao H; Yu C; Li X; Qian X; Yang X; Yang Y; Han N; Dou D; Zhang F; Ye M; Yang C; Gu Y; Dong H
Cell Death Dis; 2020 Jan; 11(1):43. PubMed ID: 31969559
[TBL] [Abstract][Full Text] [Related]
7. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
8. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
[TBL] [Abstract][Full Text] [Related]
9. LINC00969 inhibits proliferation with metastasis of breast cancer by regulating phosphorylation of PI3K/AKT and ILP2 expression through HOXD8.
Wen X; Hou Y; Zhou L; Fang X
PeerJ; 2023; 11():e16679. PubMed ID: 38130932
[TBL] [Abstract][Full Text] [Related]
10. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
[TBL] [Abstract][Full Text] [Related]
11. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
Wu M; Wen L; Zhou Y; Wu W
Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
[No Abstract] [Full Text] [Related]
12. Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer.
Zhang H; Yan C; Wang Y
J Drug Target; 2021 Nov; 29(9):1004-1015. PubMed ID: 33775192
[TBL] [Abstract][Full Text] [Related]
13. Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
Wei X; Tao S; Mao H; Zhu H; Mao L; Pei W; Shi X; Shi Y; Zhang S; Wu Y; Wei K; Wang J; Pang S; Wang W; Chen C; Yang Q
Gene; 2023 Apr; 860():147230. PubMed ID: 36717039
[TBL] [Abstract][Full Text] [Related]
14. m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization.
Chen J; Zhou Y; Wu M; Yuan Y; Wu W
Clin Breast Cancer; 2023 Jul; 23(5):546-560. PubMed ID: 37198028
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
[TBL] [Abstract][Full Text] [Related]
16. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
[TBL] [Abstract][Full Text] [Related]
19. MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6.
Lu X; Ma J; Chu J; Shao Q; Zhang Y; Lu G; Li J; Huang X; Li W; Li Y; Ling Y; Zhao T
Cell Physiol Biochem; 2017; 44(6):2346-2356. PubMed ID: 29258115
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q
Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
